Stay updated with breaking news from While Sanofi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FTC announced yesterday that it would seek to block Sanofi’s proposed exclusive license agreement with Maze Therapeutics, having concluded that the transaction would “eliminate a...
These wide-moat healthcare stocks are trading below our analysts’ fair value estimates.
French drug maker Sanofi has revised its outlook for 2022 upwards after reporting strong sales growth in the third quarter on Friday.
While major pharmaceutical companies have always been derided for considering profits over the well-being of the general population, even earning the moniker of "Big Pharma" denoting a shadow organization...
Paying for Diabetes Devices announced a new patient assistance program for current US customers who have lost their health insurance during the COVID-19 pandemic. Eligible customers can get up to two 90-day supply shipments, containing one transmitter and three boxes of three CGM sensors, for $45 each. Learn more here. Am I eligible? Current Dexcom CGM users who live in the US and are uninsured due to the COVID-19 pandemic are eligible for this program. People that have their Dexcom CGM covered by a government program such as Medicare or Medicaid are not eligible. Learn more about eligibility...